Analyst Consensus
- Current Price
- 77.38 $
- Target (Low)
- 80.00 $
- Target (Mean)
- 114.15 $
- Target (High)
- 151.40 $
- Recommendation
- Buy
- Number of Analysts
- 44
Recommendation Distribution
Recommendation Distribution| Strong Buy | 8 |
|---|
| Buy | 29 |
|---|
| Hold | 13 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 28.5%
- Operating Margin
- 32.3%
- Gross Margin
- 49.0%
- Return on Equity (ROE)
- 48.5%
- Return on Assets (ROA)
- 15.4%
- Revenue Growth
- 16.2%
- Earnings Growth
- 86.4%
- Debt/Equity
- 53.79
- Current Ratio
- 1.41
- Beta
- 1.49
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 18, 2026 | B of A Securities | Buy → Buy |
| May 15, 2026 | Guggenheim | Buy → Buy |
| Apr 17, 2026 | Piper Sandler | Overweight → Overweight |
| Apr 17, 2026 | Oppenheimer | Outperform → Outperform |
| Apr 17, 2026 | Barclays | Equal-Weight → Equal-Weight |
| Apr 17, 2026 | Citizens | Market Perform → Market Perform |